Clinical Trials Directory

Trials / Completed

CompletedNCT04696952

A Study to Evaluate Next Day Effects of TS-142 on Driving Performance in Healthy Subjects

A Driving Performance Evaluation Study of TS-142 Using a Driving Simulator in Non-elderly and Elderly Healthy Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
61 (actual)
Sponsor
Taisho Pharmaceutical Co., Ltd. · Industry
Sex
All
Age
21 Years – 79 Years
Healthy volunteers
Accepted

Summary

A clinical study to evaluate the residual effects of TS-142 on driving performance in healthy and elderly subjects.

Conditions

Interventions

TypeNameDescription
DRUGTS-142TS-142
DRUGZopicloneZopiclone
DRUGPlaceboPlacebo

Timeline

Start date
2021-01-16
Primary completion
2022-01-05
Completion
2022-01-05
First posted
2021-01-06
Last updated
2025-02-28

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT04696952. Inclusion in this directory is not an endorsement.

A Study to Evaluate Next Day Effects of TS-142 on Driving Performance in Healthy Subjects (NCT04696952) · Clinical Trials Directory